Abattis Bioceuticals Corp. | |
Stock Exchange | Other OTC |
EPS |
$0.09 |
Market Cap |
$10.58 M |
Shares Outstanding |
406.45 M |
Public Float |
- |
Abattis Bioceuticals Corp. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
406.45 M |
Public Float |
- |
Address |
970 Burrard Street Vancouver British Columbia V6Z 2R4 Canada |
Employees | - |
Website | http://www.abattis.com |
Updated | 07/08/2019 |
Abattis Bioceuticals Corp. is an agricultural technology and bio-technology company, which aggregates, integrates, and invests in agricultural technologies and biotechnology services for the legal cannabis industry developing in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets. It operates through the following segments: Sciences, Products, and Technologies. |